Pharmaceutical Industry White Papers | Pharma Adva...

Clinerion Patient Network Explorer for Global Healthcare Statistics and HEOR Research

Content Team — Tue, 07 Feb 2023 09:23:21 +0000

Clinerion’s Patient Network Explorer is a valuable resource for credible, reliable, actionable real–world data (RWD), based on electronic health records (EHRs) from Clinerion’s global hospital network.

We present an overview of the representativeness of its data and coverage, supporting applications for healthcare standards of care research, patient insights, health economic outcomes research (HEOR) and market access.

Click here to Download the full report

The post Clinerion Patient Network Explorer for Global Healthcare Statistics and HEOR Research appeared first on Pharma Advancement.

The Future of Digital Health

Content Team — Wed, 21 Feb 2018 13:00:24 +0000

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution. The importance of successfully executing a digital health strategy, as well as creating new financial models and partnerships, cannot be understated.

Nevertheless, this revolution is not often witnessed in current practice. While incorporation of digital practices has been slow, the future will move quickly. However, instead of fearing the future, the digital health transformation should have pharmaceutical leaders enthusiastic about the possibilities of the very near future.

There are clear opportunities on the horizon, and those pharma organizations and leaders who are prepared for the potential, can soon capitalize on them.

To download the complete White Paper click here

The post The Future of Digital Health appeared first on Pharma Advancement.

Five Best Practices to Deliver Exceptional Multichannel Experiences

Yuvraj_pawp — Thu, 19 Nov 2015 07:12:33 +0000

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we will discuss these five best practices for life science companies to deliver effective multichannel experiences:

1. Ensuring reliable customer data

2. Aligning communication channels

3. Creating a high-leverage content strategy

4. Personalizing the customer experience

5. Monitoring, measuring, and improving

The post Five Best Practices to Deliver Exceptional Multichannel Experiences appeared first on Pharma Advancement.

The Impact and Use of Social Media in Pharmacovigilance

Yuvraj_pawp — Thu, 19 Nov 2015 07:10:51 +0000

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more patient- centric models for reporting, analyzing and monitoring of safety data.

However, there is no magic pill or solution to the various challenges facing the industry today.

Visit the Sciformix website at www.sciformix.com

Contact Sciformix at ask@sciformix.com

The post The Impact and Use of Social Media in Pharmacovigilance appeared first on Pharma Advancement.

Leveraging Patient Feedback Data to Support Effectiveness and Demonstrate Outcomes

Yuvraj_pawp — Thu, 19 Nov 2015 07:06:20 +0000

As the healthcare landscape moves increasingly toward outcome-based treatment approaches, the need to gather and analyze real-world outcome data has become paramount to gauging medication effectiveness and subsequently recruiting prescribers as brand advocates.

This study outlines a feedback program that provides prescribers with patient results of their treatment experience in order to better inform their therapy recommendations.

The program is designed to offer a unique value proposition to both patients and physicians to drive increased participation in their treatment.

The post Leveraging Patient Feedback Data to Support Effectiveness and Demonstrate Outcomes appeared first on Pharma Advancement.

Pharmacovigilance & Risk Management for Biosimilars: Unique Challenges & Possible Solutions

Yuvraj_pawp — Thu, 19 Nov 2015 07:05:32 +0000

Biological medicines have made substantial contributions to the treatment of many chronic and serious diseases and are expected to provide significant therapeutic benefits to many patients who would otherwise have had limited treatment options.

Increasingly aging populations and this growing burden of chronic diseases have put tremendous pressure on healthcare systems all over the world, increasing demand for cost effective medicines.

This has opened up huge opportunities for follow-on biologics, or biosimilars, to enter the market and serve the needs of patients all over the world in a cost effective manner.

Click here to Download the White paper

The post Pharmacovigilance & Risk Management for Biosimilars: Unique Challenges & Possible Solutions appeared first on Pharma Advancement.

Unique Patient Challenges and Support Solutions in Rare Disease

Yuvraj_pawp — Thu, 19 Nov 2015 07:01:24 +0000

What are key challenges with treatment adherence among rare disease patients and how can we improve self-management of their condition?

In a recent White Paper, Atlantis Healthcare examines the complex landscape of rare disease and addresses how health psychology frameworks can identify barriers and facilitators of Tx adherence to drive Belief-driven Behavior ChangeTM.

The post Unique Patient Challenges and Support Solutions in Rare Disease appeared first on Pharma Advancement.

Environmental Nutrition – Redefining Healthy Food in the Health Care

Yuvraj_pawp — Wed, 18 Nov 2015 00:00:00 +0000

Healthy food cannot be defined by nutritional quality alone. It is the end result of a food system that conserves and renews natural resources, advances social justice and animal welfare, builds community wealth, and fulfills the food and nutrition needs of all eaters now and into the future.

This paper presents scientific data supporting this environmental nutrition approach, which expands the definition of healthy food beyond measurable food components such as calories, vitamins, and fats, to include the public health impacts of social, economic, and environmental factors related to the entire food system.

Adopting this broader understanding of what is needed to make healthy food shifts our focus from personal responsibility for eating a healthy diet to our collective social responsibility for creating a healthy, sustainable food system. We examine two important nutrition issues, obesity and meat consumption, to illustrate why the production of food is equally as important to consider in conversations about nutrition as the consumption of food.

The health care sector has the opportunity to harness its expertise and purchasing power to put an environmental nutrition approach into action and to make food a fundamental part of prevention-based health care.

Taking Action on Environmental Nutrition

EDUCATION
Clinicians can organize Grand Rounds at their facilities focused on an environmental nutrition issue like antibiotics overuse in food animal production to raise awareness among their colleagues about the health impacts of industrialized agriculture.

HOSPITAL FOOD PURCHASING
Food service staff can procure sustainably produced foods and beverages and support farmers, distributors, and food businesses that are actively building a healthier food system.

PUBLIC POLICY
Health professionals can leverage their health expertise and visit elected officials to advocate for public policies that promote sustainable and fair agricultural production practices.

RESEARCH
Health professionals and scientists can support and promote ongoing research on the individual and community health impacts of our current food production methods with an emphasis on agricultural inputs such as pesticides, fertilizers, fossil fuels, antibiotics, and genetically modified organisms.

HEALTH CARE WITHOUT HARM’S HEALTHY FOOD IN HEALTH CARE PROGRAM
Health Care Without Harm’s Healthy Food in Health Care program harnesses the expertise and purchasing power of the health care sector to put an environmental nutrition approach into action.

The post Environmental Nutrition – Redefining Healthy Food in the Health Care appeared first on Pharma Advancement.

CEPiA Peptides and Oligonucleotides

Yuvraj_pawp — Fri, 08 Aug 2014 12:21:14 +0000

PEPTIDES & OLIGONUCLEOTIDES
From a unique state-of-the-art platform for development and scale-up of Peptides in Frankfurt (Germany) and Oligonucleotides in Frankfurt (Germany) & Haverhill (United Kingdom), CEPiA offers customized services (manufacturing and analytical) and can provide the full scope of development activities from clinical phase up to submission and launch, including regulatory support, as well as commercial supplies.

For more information Click Here

CEPIA SANOFI

The post CEPiA Peptides and Oligonucleotides appeared first on Pharma Advancement.

Formulation Strategies for Poorly Soluble Drugs

Yuvraj_pawp — Fri, 08 Aug 2014 12:18:39 +0000

With the advent of combinatorial chemistry and high throughput screening, the number of poorly water soluble drug candidates has dramatically increased. The “drugability” of new chemical entities (NCEs) and life-cycle management of
marketed pharmaceutical products are becoming more challenging.

For more information Click Here

PATHEON

The post Formulation Strategies for Poorly Soluble Drugs appeared first on Pharma Advancement.